Guidelines for Blood Recovery and Reinfusion - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Guidelines for Blood Recovery and Reinfusion

Description:

Medical Director, Clinical Services, New York Blood Center, White Plains, NY ... Based on principles of cGMP, TQM. Contain 10 Quality system essentials ... – PowerPoint PPT presentation

Number of Views:391
Avg rating:3.0/5.0
Slides: 41
Provided by: KathleenG154
Category:

less

Transcript and Presenter's Notes

Title: Guidelines for Blood Recovery and Reinfusion


1
Guidelines for Blood Recovery and Reinfusion
  • Kathleen Grima, MD
  • Medical Director, Clinical Services, New York
    Blood Center, White Plains, NY

2
Resurging Interest in Perioperative Autologous
Activies
  • Avoidance of transfusion-transmitted infection
  • Avoidance of transfusion-related immunomodulation
  • Concerns regarding the adequacy of the blood
    supply
  • Development of new techniques

3
Perioperative Autologous Blood Practices - Scope
  • Acute normovolemic hemodilution
  • Component preparation
  • Platelet rich plasma/platelet gel
  • Cryoprecipitate/fibrin glue
  • Perioperative blood salvage
  • Intraoperative or postoperative
  • With or without washing

4
Importance of Quality
  • Goal of perioperative autologous activities is to
    ensure that a safe and quality service is
    provided
  • How does one ensure the goal is met?

5
Patient Outcome Safety
  • A therapeutic product is made
  • Processing separation, concentration, washing
  • No processing anticoagulation, filtration,
    storage
  • Techniques are evolving and information is limited

6
Patient Outcome
  • Variation in technique or device failure could
    produce an ineffective product
  • Platelet gel that does not clot due to a low
    concentration of platelets
  • ANH units that are clotted due to inadequate
    anticoagulation
  • Salvaged blood units containing large amounts of
    heparin

7
Patient Safety
  • Incorrect performance of procedure or device
    failure can result in adverse effects to patients

8
Autologous Blood - Errors
  • 64,500 blood salvage procedures
  • 11 errors (1 in 6,000 procedures)
  • 2 cases of fatal air embolism
  • 2 errors involving transfusion to the wrong
    patient
  • 6 cases of hemolysis
  • 1 case of unexplained fever
  • Linden JV. Transfusion 3428S, 1994.

9
What Defines Quality for Perioperative Activities?
  • Clinically effective product delivered to the
    right patient in the right way at the right time
    without adverse effect

10
What Influences Quality in Perioperative
Activities?
  • Infrastructure
  • Personnel, equipment, materials, environment
  • Process
  • Case selection
  • Procedural steps
  • Storage parameters
  • Administration steps
  • Adverse effects

11
How is Quality Measured?Quality Indicators
  • Product quality
  • Concentration of component
  • Removal of supernatant materials
  • Sterility
  • Patient outcome measures
  • Units of autologous blood transfused per
    procedure
  • Appropriate utilization
  • Avoidance of allogeneic blood, good outcome

12
Quality Indicators, cont.
  • Cost-effectiveness
  • Event reporting
  • Internal assessment
  • External assessment
  • JCAHO, AABB, FDA, NJDOH

13
AABB Standards for Perioperative Autologous Blood
Collection and Administration
  • Goal infrastructure to ensure the delivery of a
    consistent high quality product/service to
    patients
  • Based on principles of cGMP, TQM
  • Contain 10 Quality system essentials
  • Contain operational/technical items as well

14
QSE1 Organization
  • Medical director responsible for all policies,
    processes and procedures
  • Role of the blood bank/transfusion service
  • Setting expectations regarding service quality
    and outcome with ongoing review and improvement
  • Quality system
  • Policies, processes and procedures

15
Medical Director
  • Licensed physician qualified by training and/or
    experience
  • Responsible for all policies, processes and
    procedures

16
QSE 2 Resources
  • Personnel
  • Job description/qualification
  • Dedicated vs multitasking
  • Training
  • Periodic competency assessment
  • Do they have the time and the skills to perform
    the task effectively?

17
QSE 3 Equipment
  • Equipment
  • Device selection based on intended setting and
    outcome
  • Validation
  • Ongoing maintenance, calibration, monitoring
  • Storage and warming devices

18
Platelet Gel Production
  • Key questions
  • What types of cases will be using this product?
  • Oral surgery?
  • Plastic surgery?
  • Orthopedic surgery?
  • What volume of platelet concentration or gel is
    needed?
  • Where will the initial blood collection be
    performed?

19
Platelet Gel Production
  • Whole blood collection high or low volume
  • PRP collection blood salvage or apheresis
  • Hyperconcentration optional filter device
  • Gel formation addition of thrombin and calcium

20
Platelet Gel Production
  • Goal of Validation demonstrate that a high
    quality product can be made prior to use on
    patients
  • Minimum
  • Make platelet concentrate using a blood sample
    from a normal individual
  • Test to assure that it meets manufacturers
    specifications
  • Volume, platelet count
  • Gels with addition of thrombin and calcium

21
Platelet Gel Production
  • Academic validation
  • Prepare blood samples with varying hemoglobin
    concentrations
  • Prepare platelet concentrate in triplicate
  • Measure platelet concentration in initial samples
    PRP
  • Measure release of growth factors after gel
    formation

22
QSE 4 Supplier Customer Issues
  • Identification of critical materials services
  • Incoming receipt, inspection testing of
    critical materials
  • Expectations for support and service from
    manufacturer or service provider
  • Supplier qualification
  • Agreements

23
QSE 5 Process Control
  • SOP with change control
  • Conformance with manufacturers directions for
    use
  • Standardized procedural records
  • Defined clinical applications including
    contraindications and process for dealing with
    exceptions

24
QSE 5 Process Control
  • Defined operational parameters
  • Vacuum regulation
  • Anticoagulant solution
  • Circuit configuration
  • Filtration
  • Wash volumes
  • Standardized labeling procedures

25
Blood Salvage with Processing Case Selection
  • Indications contraindications
  • Policies on cancer, contaminated wounds,
    obstetrics, collagen preparations, Witness
    patients.
  • Process for exceptions
  • Ordering process

26
Blood Salvage with Processing Procedural Steps
  • Patient identification
  • Vacuum control
  • Suction apparatus/technique
  • Anticoagulation agent ratio
  • Policy regarding contamination, dilution with
    irrigation fluid, aspiration of medications not
    intended for IV administration

27
Blood Salvage with Processing Procedural Steps
  • Pump speeds
  • Fill, wash, empty
  • Wash parameters
  • Solution, volume, waste line monitoring
  • Technique to avoid air embolism
  • Labeling

28
Blood Salvage with Processing Procedural Steps
  • Policies on fat contamination, partial bowls,
    salvage from sponges
  • Special techniques
  • Filtration (leukocyte reduction, fat reduction,
    microaggregates)
  • irradiation

29
QSE 5 Process Control
  • Define handling, storage and expiration
    parameters
  • Standardized administration protocols including
    use of ancillary devices
  • Periodic quality testing of products
  • Tests to be performed
  • Thresholds for acceptability
  • Frequency of testing

30
Process Control Storage Handling
31
Blood Salvage with Processing Quality Assurance
  • Final product testing
  • Visual inspection
  • Weight or volume
  • Hematocrit
  • Supernatant removal (color of waste line
    residual heparin concentration albumin,
    potassium, or free hemoglobin removal)
  • Sterility

32
QSE 6 Documents Records
  • Document control
  • Master list
  • Standard format
  • Review approval process
  • Records
  • Computer systems

33
QSE 7 Nonconformances
  • Process to capture, assess, investigate, monitor
    deviations and nonconforming products/services
  • Control of nonconforming products or services
  • Process for review disposition of nonconforming
    products services
  • Process for detection, reporting, evaluation of
    adverse events

34
QSE 8 Internal External Assessments
  • External assessments (inspections, surveys)
  • Internal assessments (audits)
  • Management follow up of results
  • Utilization review

35
Utilization Review
  • Data reviewed as requested
  • Utilization by surgical service
  • Data reviewed monthly
  • Cases with not enough blood to process (7)
  • Mean yield per procedure by surgical type (2.6
    units)
  • Discard rate (1.3)
  • Proportion of all RBC units collected (15)

36
QSE 9 Process Improvement
  • Mechanism to identify improvement opportunities
  • Process for analysis and implementation
  • Corrective action
  • Preventive action

37
Process Improvement
  • Entry of results for incorrect patient
  • Root cause manual entry of 7 digit clinic
    number multiple times during process
  • Corrective action
  • Secondary review of all records by management
    staff with correction of all errors
  • Preventive action
  • Implementation of barcode labels for clinic
    number
  • Future implementation of system to directly
    download results into computer

38
QSE 10 Facilities Safety
  • Safe enviroment
  • Biological, chemical radiation safety
  • Discard of products

39
AABB Standards for Perioperative Autologous
Blood Collection Adminstration
  • AABB Guidance for Standards and AABB Guidelines
    for Blood Recovery and Reinfusion in Surgery and
    Trauma

40
Conclusions
  • The standards for perioperative autologous blood
    collection and administration provide the
    infrastructure to ensure the delivery of a
    consistent high quality product to our patients
Write a Comment
User Comments (0)
About PowerShow.com